Timothy P. Coughlin
United States of America
Mr. Timothy P. Coughlin, also known as Tim, CPA has been Executive officer of Neurocrine Biosciences, Inc. since February 25, 2017. Mr. Coughlin served as the Chief Financial Officer and Vice President of Neurocrine Biosciences, Inc. from September 2006 to February 25, 2017. He was responsible for Accounting, Finance, Information Technology and Investor Relations. Mr. Coughlin served as Controller of Neurocrine Biosciences, Inc. Prior to joining Neurocrine in 2002, he was with Catholic Health Initiatives (CHI), where he served as Vice President, Financial Services. Mr. Coughlin also served as a Senior Manager in the Health Sciences practice of Ernst & Young LLP and its predecessors, from 1989 to 1999. He has been an Independent Director at Fate Therapeutics, Inc. since August 2013 and Retrophin, Inc. since March 31, 2015. He has been a Director at aTyr Pharma, Inc. since April 10, 2011. He holds a Bachelor's degree in Accounting from Temple University and a Master's degree in International Business from San Diego State University. Mr. Coughlin is a Certified Public Accountant in both California and Pennsylvania.
Clinical Neurology and Neurosurgery